IVVD FY 2021 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena

IVVDInvivyd, Inc.

$257M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$227M

Net Income

-$227M

EPS (Diluted)

$-2.11

Cash Flow

Operating Cash Flow

-$185M

Free Cash Flow

-$185M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$620M

Total Liabilities

$62M

Stockholders' Equity

$558M

Cash & Equivalents

$542M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$227M	-$112M	-102.6%
Net Income	-$227M	-$112M	-102.5%